MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
-$40,630K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of long-t...
Share-based compensation expense
Loss on extinguishment of debt
Others
Negative Cash Flow Breakdown
Repayment of long-term debt
Net loss
Purchase of marketable securitie...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Net loss
-44,087
-38,835
-34,166
-32,785
Depreciation and amortization
2,664
2,325
1,983
2,373
Loss on disposal of property and equipment
-292
-434
-167
-280
Reserve for equipment and supplies
1,464
835
699
901
Provision for uncollectible accounts receivable
-
1,081
365
537
(recovery) provision for uncollectible accounts receivable
-817
-
-
-
Amortization (accretion) of premiums (discounts) on securities, net
890
106
-
-
Loss on extinguishment of debt
-6,304
-
-
-
Amortization of debt discounts and issuance costs
408
468
469
468
Share-based compensation expense
9,517
10,304
10,108
8,653
Non-cash lease expense
103
53
125
87
Deferred income tax expense
-
166
-
-
Change in fair value of warrant liabilities
251
-376
-232
844
Disposable medical equipment supplies
-908
8
130
-136
Prepaid expenses and other current assets
-246
984
532
-813
Accounts receivable
48
2,913
2,661
1,705
Accounts payable
-1,879
4,949
1,725
524
Accrued liabilities
-4,727
4,005
3,672
1,380
Operating lease liabilities
-190
-144
-228
-175
Other long-term assets
-2
-10
-10
-10
Net cash used in operating activities
-32,295
-18,720
-18,366
-18,343
Purchases of property and equipment
8,335
9,664
9,797
7,265
Deposits for medical rental equipment
0
1
189
235
Refund of deposits for medical rental equipment
0
0
67
80
Investment in equity security
-
0
5,000
-
Purchase of marketable securities
13,017
163,041
-
-
Net cash used in investing activities
-21,352
-172,706
-14,919
-7,420
Proceeds from issuance of long-term debt
75,000
-
-
-
Payment of debt issuance costs
3,193
-
-
-
Repayment of long-term debt
46,395
-
-
-
Proceeds from issuance of common stock
-
0
149,291
-
Payment of early termination fee on debt repayment
3,758
-
-
-
Payment of equity issuance costs
415
480
84
1,902
Deemed dividend for payments to third party on behalf of shareholder
172
298
25
-
Proceeds from stock option exercises
1,140
593
-
-
Proceeds from employee stock purchase plan
1,298
-
-
-
Tax withholdings on restricted stock unit vesting
1,010
-
-
-
Net cash provided by (used in) financing activities
22,495
-185
149,182
-27
Net decrease in cash, cash equivalents and restricted cash
-31,152
-191,611
115,897
-25,790
Beginning of period
100,044
175,758
175,758
237,929
End of period
68,892
-
-
-
Cash and cash equivalents
68,558
-
-
-
Restricted cash
334
-
-
-
Cash, cash equivalents and restricted cash
68,892
100,044
291,655
175,758
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
KMTS Cash Flow Sankey Diagram
Sankey diagram visualizing KMTS cash flow for the period
Proceeds from issuance of
long-term debt
$75,000K
Proceeds from employee
stock purchase plan
$1,298K
Proceeds from stock
option exercises
$1,140K
Net cash provided by
(used in) financing...
$22,495K
(1299.73%↑ Y/Y)
Canceled cashflow
$54,943K
Net decrease in
cash, cash...
-$31,152K
(14.37%↑ Y/Y)
Canceled cashflow
$22,495K
Share-based compensation
expense
$9,517K
(107.84%↑ Y/Y)
Loss on
extinguishment of debt
-$6,304K
Depreciation and
amortization
$2,664K
(31.36%↑ Y/Y)
Reserve for equipment
and supplies
$1,464K
Amortization of debt
discounts and issuance...
$408K
(-13.01%↓ Y/Y)
Loss on disposal of
property and equipment
-$292K
(-4.29%↓ Y/Y)
Change in fair value of
warrant liabilities
$251K
(108.63%↑ Y/Y)
Prepaid expenses and
other current assets
-$246K
(-75.71%↓ Y/Y)
Non-cash lease expense
$103K
(68.85%↑ Y/Y)
Other long-term
assets
-$2K
(80.00%↑ Y/Y)
Repayment of long-term
debt
$46,395K
Payment of early
termination fee on debt...
$3,758K
Payment of debt issuance
costs
$3,193K
Tax withholdings on
restricted stock unit...
$1,010K
Payment of equity
issuance costs
$415K
Deemed dividend for
payments to third party on...
$172K
Net cash used in
operating activities
-$32,295K
(-22.92%↓ Y/Y)
Canceled cashflow
$21,251K
Net cash used in
investing activities
-$21,352K
(-159.38%↓ Y/Y)
Net loss
-$44,087K
(-70.71%↓ Y/Y)
Accrued liabilities
-$4,727K
(-449.65%↓ Y/Y)
Accounts payable
-$1,879K
(35.12%↑ Y/Y)
Disposable medical
equipment supplies
-$908K
(-97.39%↓ Y/Y)
Amortization (accretion) of
premiums (discounts) on...
$890K
(recovery) provision for
uncollectible accounts...
-$817K
Operating lease
liabilities
-$190K
(-37.68%↓ Y/Y)
Accounts receivable
$48K
(-97.30%↓ Y/Y)
Purchase of marketable
securities
$13,017K
Purchases of property and
equipment
$8,335K
(2.07%↑ Y/Y)
Buy us a coffee
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)